Associate Professor Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She joined UK Biobank as Senior Epidemiologist in 2011, and became Chief Scientist in 2019, where she is responsible for following-up participants both through linkage with routine health-related datasets, and through web-based questionnaires. She is also involved in developing the scientific strategy for future enhancements for the study. Her research interest is largely in the role of diet, obesity and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world.
Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort.
Fortner RT. et al, (2020), Int J Cancer
Hormone-related diseases and prostate cancer: An English national record linkage study.
Watts EL. et al, (2019), Int J Cancer
BODY SIZE AND COMPOSITION IN RELATION TO RISK OF ENDOMETRIAL CANCER IN UK BIOBANK
Omiyale W. et al, (2019), JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 73, A15 - A16
High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC. et al, (2019), Cancer Res
C-reactive protein and ovarian cancer risk: Results from the Ovarian Cancer Cohort Consortium
ALLEN N., (2019), Cancer Research